| Literature DB >> 29467376 |
Jun-Ge Liang1, Nam-Young Kim2, Ara Ko3, Heung Dong Kim4,5, Dongpyo Lee6.
Abstract
Corpus callosotomy (CC) is an effective palliative surgical treatment for patients with Lennox-Gastaut Syndrome (LGS). However, research on the long-term functional effects of CC is sparse. We aimed to investigate these effects and their associated clinical conditions over the two years after CC. Long-term clinical EEG recordings of 30 patients with LGS who had good and bad seizure outcome after CC were collected and retrospectively studied. It was found that CC caused brain network 'hubs' to shift from paramedian to lateral regions in the good-recovery group, which reorganized the brain network into a more homogeneous state. We also found increased local clustering coefficients in patients with bad outcomes and decreases, implying enhanced network integration, in patients with good outcomes. The small worldness of brain networks in patients with good outcomes increased in the two years after CC, whereas it decreased in patients with bad outcomes. The covariation of small-worldness with the rate of reduction in seizure frequency suggests that this can be used as an indicator of CC outcome. Local and global network changes during the long-term state might be associated with the postoperative recovery process and could serve as indicators for CC outcome and long-term LGS recovery.Entities:
Mesh:
Year: 2018 PMID: 29467376 PMCID: PMC5821858 DOI: 10.1038/s41598-018-21764-5
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Broadband network topologies and the changes from pre-operation to three-month, one-year, and two-year postoperative states. (A) In the preoperative state, most connections located around the paramedian regions notably weakened after CC; this change generally remained consistent at three-months, one- and two-years post-operation. (B) After CC, the interhemispheric connections increased and the paramedian connections decreased; these changes persisted in the long-term recordings. The decreased connectivity at two-years was greater than the other changes.
Figure 2Hubs derived from betweenness centrality (BC) intensity for the four groups (See Supplementary Figure S3 for details). In the good outcome groups, I and II, the high BC values and the hubs were mainly distributed around the paramedian region before CC, and shifted to more lateral regions after CC. In group III, the High-Bad group, the preoperative hubs mostly focused on the frontal regions. In group IV, the Low-Bad group, although the preoperative hubs were concentrated in the midline regions, their locations were not greatly affected by CC; they were still located near the midline regions in the three-month state.
Figure 3Comparisons of local network parameters including (A) local clustering coefficient (LCC) and (B) betweenness centrality (BC). Patients in group I showed increased LCC (p < 0.001) three-months after surgery and decreased LCC (p < 0.001) at one-year and two-year post-operation (repeated measures ANOVA, F3,15 = 3.876, p = 0.031, Bonferroni post-hoc tests). For group II, LCC decreased (p ≤ 0.001) at the two-year follow-up compared to the pre-operation value (repeated measures ANOVA, F3,30 = 3.022, p = 0.045, Bonferroni post-hoc tests). Both groups III and IV showed an increased LCC (p < 0.001) after CC at one-year follow-up; group III increased further at the two-year state (repeated measures ANOVA, F3,15 = 4.101, p = 0.026, Bonferroni post hoc tests) whereas group IV decreased (repeated measures ANOVA, F3,18 = 4.495, p = 0.016, Bonferroni post hoc tests). The LCC in a fully-connected network equals 1. BC in Group I slightly decreased three-months after CC and then showed a significant increase (p < 0.05) after two years of recovery, whereas no clear changes were seen in the other groups (repeated measures ANOVA, F3,15 = 4.006, p = 0.028, Bonferroni post hoc tests).
Figure 4Comparisons of global parameters including (A) characteristic path length (CPL) and (B) global clustering coefficient (GCC). In group II the CPL showed a decrease at the two-year follow-up (p < 0.05) when compared to the pre-operation value (repeated measures ANOVA, F3,30 = 3.209, p = 0.037, Bonferroni post hoc tests), while group III showed an increasing trend and group IV showed a decreasing trend. A notable change was seen in the global clustering coefficient (GCC) of group III, in that the GCC continuously decreased (p < 0.05) for two years after CC (repeated measures ANOVA, F3,15 = 4.382, p = 0.021, Bonferroni post hoc tests). GCC also showed a decreasing trend in groups I and II. (C) Small-worldness calculated as the ratio of the global clustering coefficient to characteristic path length (error bars: standard errors). None of the groups showed statistically significant differences. However, the small-worldness of patients with good outcomes (groups I and II combined, repeated measures ANOVA, F3,48 = 3.621, p = 0.038, Bonferroni post hoc tests) increased (p = 0.03) two years after CC whereas it decreased in patients with bad outcomes. The small-worldness of a fully-connected network equals 1. (D) Simplified illustration of functional network pattern changes from pre- to post-operation.
Clinical characteristics of LGS patients.
| NO. | Sex/age | Seizure onset age | Main seizure type | CC type | Preoperative medication | Preoperative EEG | 3-month postoperative EEG | 3-month seizure outcome | 1-year postoperative EEG | 1-year seizure outcome | 2-year postoperative EEG | 2-year seizure outcome |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | M/9 | 7 | Atypical absence | Complete | OXC, LEV, TPM | GPFA, GSSW | GPFA, GSSW▼ | 60%▼ | MSWD | 90%▼ | MSWD | Seizure free |
| 2 | M/2 | 0.8 | Spasms | Partial | VGB, LEV, VPA | GPFA, GSSW | Lt LPFA, Lt SWD | 60%▼ | Lt SWD | 90%▼ | Lt SWD▼ | Seizure free |
| 3 | F/8 | 0.5 | GT | Partial | LEV, VPA, TPA | GPFA, GSSW | Lt LPFA | 90%▼ | Lt LPFA | 90%▼ | Bilateral LPFA, MSWD | Seizure free |
| 4 | F/4.1 | 2.1 | Tonic | Partial | VPA, LMT, CZM | GPFA, GSSW | Rt F SWD | Seizure free | No EFD | Seizure free | No EFD | Seizure free |
| 5 | M/4.6 | 1.1 | Atonic-drop attackGTC | Partial | TPM, LMT, LEV | GPFA, GSSW | MSWD | 93%▼ | No EFD | Seizure free | Lt T SWD | Seizure free |
| 6 | M/13.8 | 3 | Head droptonic | Complete | ZNS, CLB, LEV, TPM | GPFA, GSSW | Rt F SWD | Seizure free | MSWD | Seizure free | MSWD | Seizure free |
| 7 | F/12 | 8 | Atonic-drop attackabsence | Complete | LEV, VPA, VGB | GPFA, GSSW | No EFD | Seizure free | No EFD | Seizure free | No EFD | Seizure free |
| 8 | F/8 | 2 | GTC, head drop | Complete | LMT, ZNS, LEV, VPA | GPFA, GSSW, MSWD | Rt LPFA, Rt F SWD | Seizure free | MSWD | 99%▼ | Lt SWD | 99%▼ |
| 9 | M/7 | 0.8 | GT | Partial | ZNS, VPA, LEV | GPFA, GSSW | Lt LPFA | Seizure free | Lt SWD | 90%▼ | MSWD | 99%▼ |
| 10 | M/15.3 | 0.8 | Repetitive tonic, GTC | Complete | VPA, TPM, LEV | GPFA, GSSW | Rt T SWD | Seizure free | Rt T SWD | 99%▼ | Rt T SWD | 99%▼ |
| 11 | M/10.6 | 6 | Absence, atonic | Partial | CLB, LEV, VPA | GPFA, GSSW | Rt F SWD | Seizure free | Rt F SWD | 99%▼ | Rt F SWD | 98%▼ |
| 12 | F/18.2 | 5 | Atonic, tonic | Complete | LMT, ZNS | GPFA, GSSW | Lt SWD | Seizure free | Lt SWD | Seizure free | No EFD | 98%▼ |
| 13 | F/7.3 | 0.3 | Atonic-drop attack tonic | Complete | CLB, VGB | GPFA, GSSW | MSWD, Lt LPFA | 50%▼ | Lt SWD | 99%▼ | MSWD | 96%▼ |
| 14 | F/15 | 1.6 | GTC, jerking | Partial | TPM, OXC, VGB | GPFA, GSSW | Lt F SWD | 95%▼ | Lt F SWD | 99%▼ | Rt F SWD | 95%▼ |
| 15 | M/13 | 9 | Head drop | Partial | TPA, LMT, LEV, VPA | GPFA, GSSW | MSWD | 99%▼ | MSWD | 90%▼ | Lt SWD, MSWD | 90%▼ |
| 16 | F/7.8 | 4 | Myoclonictonic | Complete | LMT, LEV, CLB | GPFA, GSSW | Rt F SWD | 90%▼ | Rt F SWD | 98%▼ | Rt F SWD | 90%▼ |
| 17 | M/4 | 0.5 | GTC, jerking | Complete | VGB, LEV | GPFA, GSSW | GPFA, GSSW▼ | 90%▼ | Lt SWD | 90%▼ | GSSW▼ | 80%▼ |
| 18 | M/5 | 0.5 | GT, head drop | Complete | LEV, CBZ | GPFA, GSSW | Lt LPFA | 90%▼ | MSWD | 80%▼ | GPFA, GSSW▼ | 80%▼ |
| 19 | F/1 | 0.3 | Spasms | Partial | TPM, VPA | GPFA, GSSW | GPFA, GSSW▼ | 50%▼ | GPFA, GSSW▼ | 50%▼ | MSWD | 80%▼ |
| 20 | M/10 | 6 | Atypical absence, head drop | Partial | LMT, LEV, VPA | GPFA, GSSW | GPFA, GSSW▼ | 90%▼ | GPFA, GSSW▼ | 90%▼ | Rt SWD | 80%▼ |
| 21 | F/2.4 | 1 | Atonic-drop attacktonic, absence | Partial | ZNS, LEV, VPA | GPFA, GSSW | GPFA, GSSW▼ | 86%▼ | GPFA, GSSW▼ | 80%▼ | Bilateral SWD | 76%▼ |
| 22 | M/12.8 | 8 | Absence, atonic, GT | Partial | LMT, CLB, LEV, TPM | GPFA, GSSW | Rt FT SWD, Rt LPFA | 90%▼ | Rt FT SWD, Rt LPFA | 66%▼ | Bilateral SWD | 66%▼ |
| 23 | M/5.9 | 0.5 | atonic, tonic-drop attackmyoclonic | Complete | LEV | GPFA, GSSW | Lt F SWD, GPFA▼ | 93%▼ | Rt LPFA, MSWD | 76%▼ | GPFA, GSSW▼ | 66%▼ |
| 24 | M/12 | 8 | GTC, head drop | Partial | LMT, LEV, TPM | GPFA, GSSW | Rt LPFA | Seizure free | Lt F SWD | 50%▼ | GSSW▼ | 50%▼ |
| 25 | F/4 | 0.2 | GT, SMA seizure | Partial | ZNS | GPFA, GSSW | GPFA, GSSW▼ | No change | GPFA, GSSW▼ | 50%▼ | F SWD | 50%▼ |
| 26 | F/4.9 | 0.2 | repetitive tonic | Complete | CLB, ZNS | GPFA, GSSW | bilateral SWD | 60%▼ | bilateral SWD | 20%▼ | bilateral SWD | 40%▼ |
| 27 | F/6 | 0.1 | Spasms | Partial | LMT, TPM | GPFA, GSSW | Lt LPFA | 30%▼ | Lt SWD, MSWD | 30%▼ | Lt SWD | 40%▼ |
| 28 | F/6.9 | 0.1 | myoclonictonic | Partial | LMT, TPM | GPFA, GSSW | Lt SWD, Rt O SWD | 33%▼ | Lt SWD, Rt O SWD | 66%▼ | Lt SWD, Rt O SWD, GSWD▼ | 33%▼ |
| 29 | F/2.3 | 0.1 | atonic-drop attackmyoclonic, tonic | Partial | CLB, TPM, LEV | GPFA, GSSW | bilateral SWD | 50%▼ | bilateral SWD, LPFA, GSWD | 0%▼ | bilateral SWD | 30%▼ |
| 30 | M/14.8 | 10 | Atonic, tonic-drop attack | Partial | LMT, LEV, VPA | GPFA, GSSW | Lt LPFA, MSDW | 99%▼ | Lt LPFA, MSDW | 50%▼ | MSWD | 16%▼ |
F, female; M, male; Lt, left; Rt, Right; F, frontal, T, temporal, O, occipital
GT, generalized tonic; GTC, generalized tonic-clonic;
CBZ, carbamazepine; CLB, clobazam; LEV, Levetiracetam; LMT, lamotrigine; OXC, Oxcarbazepine; RFM, rufinamide; TPM, Topiramate; VGB, Vigabatrin; VPA, Valproate; ZNS, Zonisamide; TPM, Topamax (topiramate); CZM, Rivotril (clonazepam);
GPFA, generalized paroxysmal fast activity; GSSW, generalized slow sharp and wave; LPFA, localized paroxysmal fast activity; MSWD, multifocal sharp and wave discharge; SWD, sharp and wave discharges; ▼, reduction in frequency.
All seizure outcomes are in comparison to the preoperative state.
Figure 5General flow diagram of the network effects analysis.